Cite
HARVARD Citation
Yip, L. et al. (2017). The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment. Journal of thrombosis and haemostasis. pp. 2466-2467. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yip, L. et al. (2017). The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: comment. Journal of thrombosis and haemostasis. pp. 2466-2467. [Online].